AI Commoditizing Healthcare Software
Technologists argue that the proliferation of AI coding tools is commoditizing rules-based healthcare software, such as applications for prior authorization and RCM workflows. This trend is eroding traditional competitive moats built on complex business logic. As a result, vendors must increasingly differentiate themselves through proprietary data, unique workflows, and strong distribution channels.
- The global market for AI in revenue cycle management was estimated at $20.63 billion in 2024 and is projected to reach $70.12 billion by 2030. - Venture capital investment in AI-related healthcare startups reached $10.7 billion in 2025, a 24.4% increase from the $8.6 billion raised in all of 2024. - A 2025 KLAS Research report noted that while most revenue cycle outsourcing firms are investing in AI, clients have yet to see significant operational or financial impacts. - AI-powered systems can increase clean claim rates to over 95%, a significant improvement from the 75-85% average for traditional manual processes. - In prior authorization, AI tools have been shown to reduce processing times by over 30% and can provide approval recommendations in near real-time for 75% of requests. - AI-enabled startups in digital health command an 83% funding premium per round compared to their non-AI counterparts, with an average deal size of $34.4 million versus $18.8 million. - Vendors in the prior authorization space include Innovaccer, Cohere Health, and Surescripts, who are focusing on EHR integration and automating the submission process. - A key challenge for AI adoption is the quality of underlying data; if a physician's notes are unclear or incomplete, AI tools may suggest incorrect codes, leading to denials.
